∗King George’s Medical University, Lucknow, India

†Miami Cancer Institute, Baptist Health South Florida, Miami, FL

‡Bukovinian State Medical University, Chernivtsi, Ukraine

§Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India

∥Madras Medical College, Chennai, India

¶St John's Medical College, Bangalore, India

#Bardibas Field Hospital, Nepalese Army Institute of Health Sciences, Kathmandu, Nepal

∗∗All India Institute of Medical Sciences, Nagpur, India

††Department of Labour, Government of West Bengal, Kolkata, India

‡‡Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, India

§§University of Miami, Miller School of Medicine, Miami, FL.

Address correspondence and reprint requests to Teshamae Monteith, MD, University of Miami, Millar School of Medicine, Miami, FL; E-mail: [email protected]

Vinay Suresh and Mainak Bardhan Joint First authors.

Vinay Suresh, ORCiD: 0000-0002-1401-9154

Mainak Bardhan, https://orcid.org/0000-0002-4106-409X

Tirth Dave, ORCiD: 0000-0001-7935-7333

Muhammad Aaqib Shamim, ORCID: 0000-0003-3418-8171

Dilip Suresh, ORCiD: 0000-0002-5795-8485

Poorvikha Satish, ORCiD: 0000-0002-8205-1148

Bishal Dhakal, ORCiD: 0000-0001-9432-5233

Aman Bhonsale, ORCiD: 0000-0002-6518-5785

Priyanka Roy, ORCID 0009-0008-7269-7130

Bijaya Kumar Padhi, ORCID: 0000-0002-2828-2375

Teshamae Monteith, ORCiD: 0000-0001-8912-252X

PROSPERO Registration number: CRD42023440683 (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=440683)

Conflicts of Interest and Source of Funding: Teshamae Monteith has the following disclosures over the past 3 years: clinical trial site principal investigator for studies sponsored by Eli Lilly and Abbvie (all paid to the institution); participation in an advisory board/consultancy for Abbvie, Teva, Linpharma, e-Neura, Novartis, Merz, and Pfizer; educational grant from Amgen and Abbvie; personal fees from Medscape, Massachusetts Medical Society, American Headache Society, American Academy of Neurology, Neurodiem, Academic CME, Abbvie, and Novartis; and unpaid coauthor for research funded by Abbvie, Pfizer/Biohaven, and Theranica. She is an associate editor for Cephalalgia and Continuum Audio and is on the editorial board for Neurology, American Migraine Foundation, and Brain and Life Magazine. Dr Monteith has provided unpaid service on the board of directors for the International Headache Society (2021-2023) and currently on the executive board for the Florida Society of Neurology. The other authors have no conflicts of interest to declare.

Author Contributions: VS, MB, TD: drafting, revising the manuscript.

TM: overseeing, conceptualizing the work, revision of the draft.

MAS, BKP: statistical analysis.

VS, MB, DS, PS, PR, BD, AB: data mining, revising, data cleaning.

Posted history: this manuscript was previously posted to Research Square:doi:10.21203/rs.3.rs-3215981/v1, https://www.researchsquare.com/article/rs-3215981/v1

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.clinicalneuropharm.com).